Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026

Pat NegativeExceptional ItemEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹45.50

prior close

₹45.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-2.9% vs market

Pharmaceuticals peers, median of 161sector-0.3%-3.0% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 3.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-2.2

15m

-2.0

30m

+1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3-0.4-2.9-0.3-3.0

Next day

-4.6+1.1-5.7+0.3-5.0

-4.6+1.0-5.6+0.6-5.3

-0.9+2.6-3.5+1.9-2.8

+4.1+4.2-0.2+3.1+0.9

+5.4+4.2+1.2+3.6+1.8

-1.1-0.5-0.6+1.6-2.7

15d

-3.3+0.9-4.2+2.1-5.4

-4.4+1.5-5.8+2.5-6.9

-3.3+9.1-12.4+6.2-9.5

-1.4+8.1-9.5+8.2-9.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenotech Laboratories reported a net loss of Rs 107.21 lakhs for FY2026, a sharp decline from profit of Rs 561.29 lakhs in FY2025. Revenue from operations grew marginally by 1.5% to Rs 3,956.20 lakhs. Profit before tax dropped significantly to Rs 418.90 lakhs from Rs 1,069.19 lakhs in the previous year. The company recorded exceptional items of Rs 19.51 lakhs due to Labour Code changes. Tax adjustments were substantial, including MAT credit reversal of Rs 187.47 lakhs and deferred tax charge of Rs 157.82 lakhs. Despite the loss, operating cash flow remained positive at Rs 1,020.48 lakhs. The statutory auditor issued an unmodified (clean) opinion on the financial statements.

Likely market impact

The company turned loss-making in FY2026 with PAT negative, primarily due to increased expenses and significant tax reversals. However, strong cash generation and clean audit opinion provide some comfort to shareholders.